03/18/2024 4:35 PM | GLAZER CAPITAL, LLC (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13G | |
03/13/2024 3:14 PM | GAMCO INVESTORS, INC. ET AL (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13D/A | |
03/11/2024 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
03/11/2024 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
03/11/2024 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
03/11/2024 4:24 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:25 PM | Harpoon Therapeutics (Issuer) Walker Luke Nathaniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 4:26 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:26 PM | Harpoon Therapeutics (Issuer) SILVERNAIL LAUREN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:28 PM | Harpoon Therapeutics (Issuer) Lathi Vijay K (Reporting) New Leaf Biopharma Opportunities II, L.P. (Reporting) New Leaf BPO Associates II, L.P. (Reporting) New Leaf BPO Management II, L.L.C (Reporting) New Leaf Venture Associates III, L.P. (Reporting) New Leaf Venture Management III, L.L.C. (Reporting) New Leaf Ventures III, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:15 PM | Bucher James B (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:16 PM | BAILES JOSEPH S (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:17 PM | EASTLAND JULIA MARIE (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:17 PM | Harpoon Therapeutics (Issuer) Lanza Frank J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:18 PM | Harpoon Therapeutics (Issuer) Robbins Andrew R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:19 PM | DRACHMAN JONATHAN G (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 4:22 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 2:27 PM | Harpoon Therapeutics (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 2:19 PM | Harpoon Therapeutics (Subject) MERCK SHARP & DOHME LLC (Filed by)
| Form SC 13D/A | |
03/11/2024 9:09 AM | Harpoon Therapeutics (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/11/2024 8:49 AM | Harpoon Therapeutics (Filer)
| Form POS AM | |
03/11/2024 8:51 AM | Harpoon Therapeutics (Filer)
| Form POS AM | |
03/11/2024 8:55 AM | Harpoon Therapeutics (Filer)
| Form POS AM | |
03/11/2024 8:40 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:42 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:44 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:46 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:32 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:36 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 8:37 AM | Harpoon Therapeutics (Filer)
| Form S-8 POS | |
03/11/2024 7:47 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2024 6:37 AM | Harpoon Therapeutics (Filer)
| Form DEFA14A | |
02/28/2024 6:34 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 7:32 AM | Harpoon Therapeutics (Filer)
| Form DEFA14A | |
02/22/2024 7:31 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 3:43 PM | Arix Bioscience plc (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13D/A | |
02/14/2024 5:18 PM | CITADEL ADVISORS LLC (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 8:04 PM | Harpoon Therapeutics (Subject) New Leaf Ventures III, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024 4:09 PM | Artal International S.C.A. (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 6:00 AM | Harpoon Therapeutics (Filer)
| Form DEFM14A | |
01/29/2024 3:52 PM | Harpoon Therapeutics (Filer)
| Form PREM14A | |
A lot of people are making this costly mistake (Ad) You may have heard the saying “options are risky” …
And, they can be. But only if you use them the way a lot of folks do.
A lot of people think of BUYING speculative options when they talk about options.
And BUYING low probability, speculative options is definitely risky…
It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one |
01/29/2024 3:28 PM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:19 PM | Harpoon Therapeutics (Subject) INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A | |
01/17/2024 4:52 PM | Harpoon Therapeutics (Issuer) Merck & Co., Inc. (Reporting) MERCK SHARP & DOHME LLC (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/10/2024 4:05 PM | Harpoon Therapeutics (Subject) MERCK SHARP & DOHME LLC (Filed by)
| Form DFAN14A | |
01/09/2024 3:30 PM | EASTLAND JULIA MARIE (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:30 PM | Harpoon Therapeutics (Issuer) Lanza Frank J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:30 PM | Harpoon Therapeutics (Issuer) Walker Luke Nathaniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:15 PM | Harpoon Therapeutics (Subject) MERCK SHARP & DOHME LLC (Filed by)
| Form DFAN14A | |
01/08/2024 4:16 PM | Harpoon Therapeutics (Filer)
| Form DEFA14A | |
01/08/2024 4:20 PM | Harpoon Therapeutics (Filer)
| Form DEFA14A | |
01/08/2024 7:01 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:04 AM | Harpoon Therapeutics (Filer)
| Form DEFA14A | |
01/05/2024 4:04 PM | Harpoon Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/03/2024 3:30 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:30 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2024 3:30 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 3:10 PM | Bucher James B (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 3:06 PM | Harpoon Therapeutics (Filer)
| Form 424B3 | |
12/19/2023 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
11/28/2023 3:29 PM | Harpoon Therapeutics (Issuer) SILVERNAIL LAUREN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:22 PM | BAILES JOSEPH S (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:23 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:25 PM | DRACHMAN JONATHAN G (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:25 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:26 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/28/2023 3:28 PM | Harpoon Therapeutics (Issuer) Robbins Andrew R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:01 PM | Harpoon Therapeutics (Filer)
| Form 424B5 | |
11/24/2023 1:06 PM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:31 PM | Harpoon Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
11/06/2023 3:34 PM | CITADEL ADVISORS LLC (Filed by) Harpoon Therapeutics (Subject)
| Form SC 13G | |
10/27/2023 3:41 PM | Harpoon Therapeutics (Issuer) Lathi Vijay K (Reporting) New Leaf Biopharma Opportunities II, L.P. (Reporting) New Leaf BPO Associates II, L.P. (Reporting) New Leaf BPO Management II, L.L.C (Reporting) New Leaf Venture Associates III, L.P. (Reporting) New Leaf Venture Management III, L.L.C. (Reporting) New Leaf Ventures III, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/26/2023 4:00 PM | Harpoon Therapeutics (Subject) Soleus Private Equity Fund III, L.P. (Filed by)
| Form SC 13G | |
10/23/2023 7:00 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:34 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:35 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 4:36 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:15 PM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/01/2023 11:00 AM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/06/2023 5:34 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 5:36 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/06/2023 5:37 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:53 PM | Harpoon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 3:38 PM | Harpoon Therapeutics (Issuer) Robbins Andrew R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:40 PM | Harpoon Therapeutics (Issuer) SILVERNAIL LAUREN P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:28 PM | BAILES JOSEPH S (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:29 PM | Chin Mark (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:32 PM | DRACHMAN JONATHAN G (Reporting) Harpoon Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:34 PM | Harpoon Therapeutics (Issuer) HUNT RONALD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 3:36 PM | Harpoon Therapeutics (Issuer) Myers Scott Dunseth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2023 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
the most reliable asset on earth is making a comeback (Ad) Global tensions have been pushing the price of gold to all time highs…
Just recently, gold peaked at a record $2,000 (and is now closer to $2,200).
And there’s something else critical at play right now in the world’s largest asset.
Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold.
And as we speak, some are even calling for a massive rally in the precious metal. And you can see how it works for FREE when you Click Here |
05/30/2023 3:48 PM | Harpoon Therapeutics (Filer)
| Form 424B3 | |
05/15/2023 11:15 PM | Harpoon Therapeutics (Filer)
| Form EFFECT | |
05/16/2023 5:09 AM | Harpoon Therapeutics (Filer)
| Form 424B5 | |
05/11/2023 3:36 PM | Harpoon Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/21/2023 4:17 PM | Harpoon Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
04/07/2023 3:15 PM | Harpoon Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/30/2023 3:43 PM | Harpoon Therapeutics (Subject) New Leaf Ventures III, L.P. (Filed by)
| Form SC 13G/A | |